BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35525161)

  • 1. Overall survival is the lowest among young women with postpartum breast cancer.
    Shagisultanova E; Gao D; Callihan E; Parris HJ; Risendal B; Hines LM; Slattery ML; Baumgartner K; Schedin P; John EM; Borges VF
    Eur J Cancer; 2022 Jun; 168():119-127. PubMed ID: 35525161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Postpartum Breast Cancer Diagnosis and Metastasis and the Clinical Features Underlying Risk.
    Goddard ET; Bassale S; Schedin T; Jindal S; Johnston J; Cabral E; Latour E; Lyons TR; Mori M; Schedin PJ; Borges VF
    JAMA Netw Open; 2019 Jan; 2(1):e186997. PubMed ID: 30646210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and prognosis of postpartum breast cancer.
    Paik PS; Choi JE; Lee SW; Lee YJ; Kang YJ; Lee HJ; Bae SY;
    Breast Cancer Res Treat; 2023 Nov; 202(2):275-286. PubMed ID: 37542632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Young-Onset Breast Cancer Outcomes by Time Since Recent Childbirth in Utah.
    Zhang Z; Bassale S; Jindal S; Fraser A; Guinto E; Anderson W; Mori M; Smith KR; Schedin P
    JAMA Netw Open; 2022 Oct; 5(10):e2236763. PubMed ID: 36239933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postpartum diagnosis demonstrates a high risk for metastasis and merits an expanded definition of pregnancy-associated breast cancer.
    Callihan EB; Gao D; Jindal S; Lyons TR; Manthey E; Edgerton S; Urquhart A; Schedin P; Borges VF
    Breast Cancer Res Treat; 2013 Apr; 138(2):549-59. PubMed ID: 23430224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postpartum breast cancer has a distinct molecular profile that predicts poor outcomes.
    Jindal S; Pennock ND; Sun D; Horton W; Ozaki MK; Narasimhan J; Bartlett AQ; Weinmann S; Goss PE; Borges VF; Xia Z; Schedin P
    Nat Commun; 2021 Nov; 12(1):6341. PubMed ID: 34732713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postpartum breast cancer progression is driven by semaphorin 7a-mediated invasion and survival.
    Tarullo SE; Hill RC; Hansen KC; Behbod F; Borges VF; Nelson AC; Lyons TR
    Oncogene; 2020 Mar; 39(13):2772-2785. PubMed ID: 32020054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Worse histopathology and prognosis in women with breast cancer diagnosed during the second trimester of pregnancy.
    Gkekos L; Lundberg FE; Humphreys K; Fredriksson I; Johansson ALV
    ESMO Open; 2024 Apr; 9(4):102972. PubMed ID: 38520846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of pregnancy-associated breast cancer: a meta-analysis.
    Shao C; Yu Z; Xiao J; Liu L; Hong F; Zhang Y; Jia H
    BMC Cancer; 2020 Aug; 20(1):746. PubMed ID: 32778072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognosis of women diagnosed with breast cancer before, during and after pregnancy: a meta-analysis.
    Hartman EK; Eslick GD
    Breast Cancer Res Treat; 2016 Nov; 160(2):347-360. PubMed ID: 27683280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Data describing the poor outcome associated with a breast cancer diagnosis in the post-weaning period.
    Lefrère H; Floris G; Schmidt MK; Neven P; Warner E; Cardonick E; Peccatori FA; Loibl S; Maggen C; De Mulder H; Jerzak KJ; Lambrechts D; Lenaerts L; Amant F
    Data Brief; 2021 Oct; 38():107354. PubMed ID: 34557571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes and prognostic biomarkers among pregnant, post-partum and nulliparous women with breast cancer: a prospective cohort study.
    Jerzak KJ; Lipton N; Nofech-Mozes S; Boles D; Slodkowska E; Pond GR; Warner E
    Breast Cancer Res Treat; 2021 Oct; 189(3):797-806. PubMed ID: 34318391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Premenopausal women with breast cancer in the early post-partum period show molecular profiles of invasion and are associated with poor prognosis.
    Nimbalkar VP; Snijesh VP; Rajarajan S; Alexander A; Kaluve R; Ramesh R; Srinath BS; Prabhu JS
    Breast Cancer Res Treat; 2023 Jul; 200(1):139-149. PubMed ID: 37160509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer diagnosed in the post-weaning period is indicative for a poor outcome.
    Lefrère H; Floris G; Schmidt MK; Neven P; Warner E; Cardonick E; Peccatori FA; Loibl S; Maggen C; De Mulder H; Jerzak KJ; Lambrechts D; Lenaerts L; Amant F
    Eur J Cancer; 2021 Sep; 155():13-24. PubMed ID: 34330022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal survival of patients with pregnancy-associated cancers in Taiwan - A national population-based study.
    Li SS; Hsu YT; Yen CC; Chen YW; Wu PY; Chang KC; Li CY; Chen TY
    Cancer Med; 2020 Dec; 9(24):9431-9444. PubMed ID: 33099894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of pregnancy and mortality in women diagnosed with breast cancer: A Nationwide Population Based Study in Taiwan.
    Chuang SC; Lin CH; Lu YS; Hsiung CA
    Int J Cancer; 2018 Nov; 143(10):2416-2424. PubMed ID: 30070358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the Timing of Pregnancy With Survival in Women With Breast Cancer.
    Iqbal J; Amir E; Rochon PA; Giannakeas V; Sun P; Narod SA
    JAMA Oncol; 2017 May; 3(5):659-665. PubMed ID: 28278319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Age on Breast Cancer Patient Prognoses: A Population-Based Study Using the SEER 18 Database.
    Chen HL; Zhou MQ; Tian W; Meng KX; He HF
    PLoS One; 2016; 11(10):e0165409. PubMed ID: 27798652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of time since last birth, age at first birth and parity with breast cancer survival among parous women: a register-based study from Norway.
    Alsaker MD; Opdahl S; Romundstad PR; Vatten LJ
    Int J Cancer; 2013 Jan; 132(1):174-81. PubMed ID: 22511284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy-associated breast cancer: does timing of presentation affect outcome?
    Crown A; McCartan D; Curry MA; Patil S; Kamer S; Goldfarb S; Gemignani ML
    Breast Cancer Res Treat; 2023 Apr; 198(2):283-294. PubMed ID: 36662395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.